Literature DB >> 15752459

Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.

Robert G Salomon1.   

Abstract

The cyclooxygenase (COX) pathway generates enantiomerically pure levuglandin (LG) E(2) by a rearrangement of the prostaglandin (PG) endoperoxide PGH(2). The isoprostane pathway generates racemic LGE(2) together with stereoisomers, designated collectively as isoLGE(2), through free radical-induced lipid oxidation. Within seconds, both LGs and isoLGs are rapidly sequestered by protein adduction. In theory, the diastereomeric purity of LGE(2)-protein adduct-derived lysyl lactams can reveal the relative contributions of the COX and isoprostane pathways to LGE(2) stereoisomer production in vivo. Notably, however, the detection of LGE(2)-protein adducts does not provide a basis for inferring their formation through the isoprostane pathway in vivo unless the COX pathway can be rigorously excluded. In contrast, LGE(2)structural isomers, designated collectively as iso[n]LGE(2)s, are produced exclusively through the isoprostane pathway. Immunoassays that selectively recognize iso[n]LGE(2)-protein adducts are the only tools available to unambiguously detect and quantify the production of isolevuglandins in vivo through free radical-induced oxidation of arachidonates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752459     DOI: 10.1016/j.chemphyslip.2004.12.003

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  12 in total

1.  On-tissue chemical derivatization of 3-methoxysalicylamine for MALDI-imaging mass spectrometry.

Authors:  Almary Chacon; Irene Zagol-Ikapitte; Venkataraman Amarnath; Michelle L Reyzer; John A Oates; Richard M Caprioli; Olivier Boutaud
Journal:  J Mass Spectrom       Date:  2011-08       Impact factor: 1.982

Review 2.  Clinical Relevance of Biomarkers of Oxidative Stress.

Authors:  Jeroen Frijhoff; Paul G Winyard; Neven Zarkovic; Sean S Davies; Roland Stocker; David Cheng; Annie R Knight; Emma Louise Taylor; Jeannette Oettrich; Tatjana Ruskovska; Ana Cipak Gasparovic; Antonio Cuadrado; Daniela Weber; Henrik Enghusen Poulsen; Tilman Grune; Harald H H W Schmidt; Pietro Ghezzi
Journal:  Antioxid Redox Signal       Date:  2015-10-26       Impact factor: 8.401

3.  Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.

Authors:  Yu-Shiuan Cheng; Wenyuan Yu; Yunfeng Xu; Robert G Salomon
Journal:  J Nat Prod       Date:  2017-02-14       Impact factor: 4.050

Review 4.  Isolevuglandin adducts in disease.

Authors:  Robert G Salomon; Wenzhao Bi
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

Review 5.  Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics.

Authors:  Bharathi Govindarajan; James Laird; Ronald Sherman; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

6.  Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice.

Authors:  Sanjoy Roychowdhury; Megan R McMullen; Michele T Pritchard; Wei Li; Robert G Salomon; Laura E Nagy
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

7.  Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.

Authors:  Wei Li; James M Laird; Liang Lu; Sanjoy Roychowdhury; Laura E Nagy; Rong Zhou; John W Crabb; Robert G Salomon
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

8.  Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.

Authors:  Erica J Carrier; Venkataraman Amarnath; John A Oates; Olivier Boutaud
Journal:  Biochemistry       Date:  2009-11-17       Impact factor: 3.162

9.  Isolevuglandin-modified proteins, including elevated levels of inactive calpain-1, accumulate in glaucomatous trabecular meshwork.

Authors:  Bharathi Govindarajan; James Laird; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  Biochemistry       Date:  2007-12-18       Impact factor: 3.162

10.  Increased isolevuglandin-modified proteins in glaucomatous astrocytes.

Authors:  Bharathi Govindarajan; Anna Junk; Mabel Algeciras; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  Mol Vis       Date:  2009-06-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.